FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947352885> ?p ?o ?g. }

• W2947352885 abstract "1533 Background: In the United States, cancer is the second leading cause of mortality, and millions more battle cancer worldwide. As such, primary prevention of cancer is a major interest globally. Aspirin has been studied as a primary prevention method for multiple diseases, mainly cardiovascular disease and various forms of cancer. The role of aspirin as a primary prevention of cancer is still controversial and may be more beneficial in certain cancers over others. With rapidly surfacing large randomized controlled trials (RCTs) studying this subject, we aimed to evaluate the efficacy and safety of aspirin as a primary prophylaxis for cancer. Methods: A comprehensive electronic database search was conducted for all RCTs that compared aspirin versus placebo for the prevention of any type of disease, and where cancer incidence or mortality was reported. The primary outcome was cancer-related mortality. Secondary outcomes were cancer incidence, all-cause mortality, major bleeding, any bleeding and gastrointestinal (GI) bleeding. We calculated risk ratios (RRs) and 95% confidence intervals (CIs) using a random-effects model at the longest follow-up period. Results: We included 16 RCTs with 104,018total patients, mean age of 60.51 years, mean follow-up of 5.48 years, and a male percentage of 38.72%. We found that aspirin was not associated with a significant reduction of cancer-related mortality compared with placebo (RR 0.99; 95% CI: 0.87-1.12; P = 0.85: I 2 = 41%). Compared with placebo, aspirin was not associated with significant reduction of all-cause mortality (RR 0.97; 95% CI: 0.92-1.02; P = 0.19; I 2 = 13%) or cancer incidence (RR: 0.98; 95% CI: 0.92-1.04; P = 0.43; I 2 = 16%). However, aspirin treatment was associated with significantly increased risks of any bleeding (RR 1.63; 95% CI: 1.31-2.03; P < 0.01), major bleeding (RR 1.41; 95% CI: 1.26-1.57; P < 0.01), and GI bleeding (RR 1.85; 95% CI: 1.38-2.48; P < 0.01) compared with placebo. Conclusions: Our study did not find any significant reductions in cancer-related mortality or cancer incidence when compared with placebo. Our study also highlights the dangers of aspirin for primary prevention of cancer as aspirin was found to cause higher rates of bleeding (any bleeding, major bleeding, and GI bleeding) compared to placebo at the longest follow-up period with no significant benefit in cancer primary prevention." @default.
• W2947352885 created "2019-06-07" @default.
• W2947352885 creator A5007236274 @default.
• W2947352885 creator A5009068237 @default.
• W2947352885 creator A5009545590 @default.
• W2947352885 creator A5009950624 @default.
• W2947352885 creator A5027541628 @default.
• W2947352885 creator A5048351300 @default.
• W2947352885 creator A5069249040 @default.
• W2947352885 creator A5071505108 @default.
• W2947352885 creator A5079127024 @default.
• W2947352885 creator A5082033474 @default.
• W2947352885 creator A5090968514 @default.
• W2947352885 date "2019-05-20" @default.
• W2947352885 modified "2023-09-24" @default.
• W2947352885 title "Safety and efficacy of aspirin for primary prevention of cancer: A meta-analysis of randomized controlled trials." @default.
• W2947352885 doi "https://doi.org/10.1200/jco.2019.37.15_suppl.1533" @default.
• W2947352885 hasPublicationYear "2019" @default.
• W2947352885 type Work @default.
• W2947352885 sameAs 2947352885 @default.
• W2947352885 citedByCount "0" @default.
• W2947352885 crossrefType "journal-article" @default.
• W2947352885 hasAuthorship W2947352885A5007236274 @default.
• W2947352885 hasAuthorship W2947352885A5009068237 @default.
• W2947352885 hasAuthorship W2947352885A5009545590 @default.
• W2947352885 hasAuthorship W2947352885A5009950624 @default.
• W2947352885 hasAuthorship W2947352885A5027541628 @default.
• W2947352885 hasAuthorship W2947352885A5048351300 @default.
• W2947352885 hasAuthorship W2947352885A5069249040 @default.
• W2947352885 hasAuthorship W2947352885A5071505108 @default.
• W2947352885 hasAuthorship W2947352885A5079127024 @default.
• W2947352885 hasAuthorship W2947352885A5082033474 @default.
• W2947352885 hasAuthorship W2947352885A5090968514 @default.
• W2947352885 hasConcept C121608353 @default.
• W2947352885 hasConcept C126322002 @default.
• W2947352885 hasConcept C143998085 @default.
• W2947352885 hasConcept C168563851 @default.
• W2947352885 hasConcept C2777628954 @default.
• W2947352885 hasConcept C2780234812 @default.
• W2947352885 hasConcept C71924100 @default.
• W2947352885 hasConcept C95190672 @default.
• W2947352885 hasConceptScore W2947352885C121608353 @default.
• W2947352885 hasConceptScore W2947352885C126322002 @default.
• W2947352885 hasConceptScore W2947352885C143998085 @default.
• W2947352885 hasConceptScore W2947352885C168563851 @default.
• W2947352885 hasConceptScore W2947352885C2777628954 @default.
• W2947352885 hasConceptScore W2947352885C2780234812 @default.
• W2947352885 hasConceptScore W2947352885C71924100 @default.
• W2947352885 hasConceptScore W2947352885C95190672 @default.
• W2947352885 hasLocation W29473528851 @default.
• W2947352885 hasOpenAccess W2947352885 @default.
• W2947352885 hasPrimaryLocation W29473528851 @default.
• W2947352885 hasRelatedWork W2024798652 @default.
• W2947352885 hasRelatedWork W2025259015 @default.
• W2947352885 hasRelatedWork W2063675387 @default.
• W2947352885 hasRelatedWork W2074114722 @default.
• W2947352885 hasRelatedWork W2100089051 @default.
• W2947352885 hasRelatedWork W2118928861 @default.
• W2947352885 hasRelatedWork W2130549133 @default.
• W2947352885 hasRelatedWork W2153170655 @default.
• W2947352885 hasRelatedWork W2260139112 @default.
• W2947352885 hasRelatedWork W2313869442 @default.
• W2947352885 hasRelatedWork W2422843152 @default.
• W2947352885 hasRelatedWork W2431310303 @default.
• W2947352885 hasRelatedWork W2507118501 @default.
• W2947352885 hasRelatedWork W2591545583 @default.
• W2947352885 hasRelatedWork W2735034725 @default.
• W2947352885 hasRelatedWork W2943693578 @default.
• W2947352885 hasRelatedWork W2952550907 @default.
• W2947352885 hasRelatedWork W2965999831 @default.
• W2947352885 hasRelatedWork W3010716787 @default.
• W2947352885 hasRelatedWork W3030100410 @default.
• W2947352885 isParatext "false" @default.
• W2947352885 isRetracted "false" @default.
• W2947352885 magId "2947352885" @default.
• W2947352885 workType "article" @default.